Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
about
Imaging radiation response in tumor and normal tissue.Validation of functional imaging as a biomarker for radiation treatment responseThe use and misuse of positron emission tomography in lung cancer evaluationPrognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancerFunctional and molecular image guidance in radiotherapy treatment planning optimization.(18)F-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer.Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer.PET and PET-CT in radiation treatment planning for lung cancer.Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription.Individualization of cancer treatment from radiotherapy perspective.Predictive treatment management: incorporating a predictive tumor response model into robust prospective treatment planning for non-small cell lung cancer.A geometric atlas to predict lung tumor shrinkage for radiotherapy treatment planning.Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review.Adaptive radiation for lung cancer.Impact of moving target on measurement accuracy in 3D and 4D PET imaging-a phantom study.Dose escalation for locally advanced lung cancer using adaptive radiation therapy with simultaneous integrated volume-adapted boost.Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy.Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.Potential for adaptive dose escalation in radiotherapy for patients with locally advanced non-small-cell lung cancer in a low mid income setting.A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer.
P2860
Q26798266-D2B9AEBF-FD9D-4C8F-9FDA-00FBFFD23BD4Q26823165-C1CE53FB-8CDD-439E-A40E-CAE304D194F2Q27021838-4B327BE3-2C74-4B36-9D57-1924FD846557Q30316974-7681028C-8BC5-478A-8D9B-CC4703BC1E4FQ34706820-4E033712-806F-4657-8116-98B3CAF32254Q35870847-05009040-DF4F-4DED-BFC6-78859CF5BFF9Q36014679-807CA0D5-D46C-47BC-89E5-8E09FAC4F3E9Q36261387-6DEE072A-90CF-426B-A8BA-F3145C26ADD1Q37037949-21FAA3A5-718F-400F-A06B-6240A630B13BQ37732292-8AD81F46-2698-4F55-B697-3F07817B3659Q37847721-FE3F3D10-C512-4D7B-80C2-3E24D511FAA9Q37989616-E36A7BD4-CD0B-4020-BBFE-4B9F3C1DDC9FQ38903628-A0BE3987-16A4-498B-A015-36CB7A8D4AD1Q39029314-EB23C1C9-5983-4EFC-BE36-660C86D5263DQ39417217-C9D44088-8B18-4AED-B739-7B27ADBAABA2Q39841301-DF884F74-EF30-4E6B-A5BB-1874889B60E2Q41039688-0CBFC7DD-6A9B-4A87-B834-3C353CF75B73Q41110142-88D0FF61-DD29-4585-8779-47F8772127ADQ43281500-65EF9F8F-DCB7-4132-BE2F-824E1D4DC4E3Q47898194-1B20F8E6-EDB7-4E71-B195-873140D89F24Q48015862-4982F999-8D98-4601-92A8-8D44B193CA7FQ48920934-1B4E48CF-F97B-4CC2-BED7-B57849B10981Q52649579-CBA3E23E-0943-42DD-BB2C-377C7DE526DE
P2860
Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Additional PET/CT in week 5-6 ...... s of dose escalation planning?
@en
Additional PET/CT in week 5-6 ...... s of dose escalation planning?
@nl
type
label
Additional PET/CT in week 5-6 ...... s of dose escalation planning?
@en
Additional PET/CT in week 5-6 ...... s of dose escalation planning?
@nl
prefLabel
Additional PET/CT in week 5-6 ...... s of dose escalation planning?
@en
Additional PET/CT in week 5-6 ...... s of dose escalation planning?
@nl
P2093
P1476
Additional PET/CT in week 5-6 ...... s of dose escalation planning?
@en
P2093
Carsten Evers
Charles Gillham
Daniel Zips
Falk Pönisch
Jörg Kotzerke
Jörg Steinbach
Klaus Zöphel
Nasreddin Abolmaali
Steffen Appold
Thomas Herrmann
P304
P356
10.1016/J.RADONC.2008.05.004
P577
2008-05-29T00:00:00Z